suPARnostic® Quick Triage for Point of Care suPAR Testing

About the suPARnostic® Quick Triage

suPARnostic® Quick Triage is a point-of-care test for rapid, quantitative measurement of suPAR levels. It provides healthcare professionals with immediate insight into patient prognosis, disease severity, progression, and overall health outcomes. Because results are delivered on site – without the need for core laboratory processing – the test supports efficient patient triage, timely intervention, and effective risk stratification.

Read more about suPAR here.

The suPARnostic® Quick Triage test is used together with the suPARnostic® QT FLEX Reader and delivers:

  • Simple and easy-to-operate test
  • Quick and fully quantitative suPAR results
  • Early results for better triage of patients in Emergency Department settings

The test is a 20-minute lateral flow immunoassay that measures soluble urokinase Plasminogen Activator Receptor (suPAR) levels in human EDTA plasma. suPAR is a marker of immune activation and inflammation, and higher levels are associated with increased risk of disease progression and poorer prognosis.

How the suPARnostic® Quick Triage Works

A 10 µL fresh EDTA plasma sample is mixed with 100 µL assay buffer, and 60 µL of this mix is applied to the suPARnostic® Quick Triage cassette. The cassette is incubated for 20 minutes either on the table (manual method) or inside the reader (automated method). After incubation, the connected reader analyzes the cassette and provides a quantitative suPAR concentration (ng/mL), supporting rapid patient risk stratification and triage decisions in emergency and acute care settings.

Why Choose suPARnostic® Quick Triage?

  • Rapid, reliable and fully quantitative suPAR results for better triage of patients in Emergency Department settings: The suPARnostic® Quick Triage test measures SUPAR levels in K2EDTA plasma and delivers actionable results in just 20 minutes. This speed allows clinicians to make faster triage decisions directly at the point of care in great urgency.
  • Improved emergency department workflow: By identifying high-risk patients early, the test helps clinicians prioritize urgent cases and streamline processes in busy emergency departments. This supports better patient flow and reduces delays in critical care.
  • Accuracy and ease of use: With its simple procedure, fast turnaround time, and validated prognostic accuracy, the suPARnostic® Quick Triage test is a trusted solution for hospitals looking to optimize resource allocation and achieve better patient outcomes.

Quick Triage test

Product Details

The suPARnostic® Quick Triage test is based on the lateral flow principle. The test device consists of a nitrocellulose membrane with two immobilized antibody zones and a running buffer. The QT FLEX Reader reads the quantitative results with a detection interval of 1–15 ng/mL suPAR.

This easy-to-use test offers a short and straightforward procedure with fully quantitative results, enabling the clinician to act immediately if suPAR levels are abnormal.

  • Format: Lateral flow immunoassay (single-use cassette read by QT FLEX  Reader)
  • Assay Time: 20 minutes
  • Sample Type: Fresh K₂-EDTA plasma (10 µL)
  • Shelf Life: As printed on foil pouch; typically 36 months when stored at 18–24 °C in sealed packaging

Product contains

  • 25 lateral flow Quick Triage Test Devices
  • Running Buffer Solution
  • Instructions for Use
  • QR code cards with a lot-specific method

Product Code

Product no. A003: suPARnostic® Quick Triage kit with 25 tests

Documentation

See technical documents

Product Details

suPARnostic® QT FLEX Reader
The suPARnostic® QT FLEX Reader is a highly sensitive, robust, and cost-effective measurement system for lateral flow tests. This flexible and reliable system, based on a ready-to-use concept, enables the users to easily run lateral flow tests.

Product contains

  • suPARnostic® QT FLEX Reader instrument
  • Quick Start guide
  • Power supply including international connection adapter
  • Network Cable and USB to Ethernet Adaptor

Benefits

  • Designed for easy operation
  • Graphical user interface on the integrated touch display
  • Easy result management

Product Code

A006: suPARnostic® QT FLEX reader

Documentation

See technical documents

Note:

Assay settings are performed using Method Files that are specific to a particular each suPARnostic® Quick Triage assay batch and are located within each suPARnostic® Quick Triage Kit.

Want to buy suPARnostic® Quick Triage?

FAQs

suPAR is the soluble urokinase plasminogen activator receptor — a circulating form of the receptor (uPAR) that can reflect immune activation and inflammation.

It is intended for use as an aid in the detection and evaluation of inflammatory disorders and immune activation.

The suPARnostic® Quick Triage test provides a quantitative result in approximately 20 minutes. The test cassette incubates for 20 minutes — either on the bench (manual mode) or inside the reader (automated mode) — after which the reader performs an automated optical analysis (< 20 seconds) and displays the result immediately.

The test uses freshly isolated K2-EDTA plasma. Samples must not be frozen and should be analyzed within 24 hours at room temperature or within 3 days if stored at 2–8°C.

Only 10 µL of plasma is required per test. It is mixed with 100 µL of assay running buffer, and 60 µL of the mixture is applied to the test cassette.

The test must be read using the suPARnostic® QT FLEX Reader (or the older aLF Reader). Optional accessories include a Dymo printer and barcode reader for data management and labeling.

  • QT Method: The test incubates on a table for 20 minutes before being inserted into the reader.
  • QT20 Method: The test incubates inside the reader, which controls timing automatically.

suPARnostic® Quick Triage results should be interpreted as follows:

suPAR Level (ng/mL)Risk CategoryClinical InterpretationRecommended Action
< 4.0Low RiskLow inflammation / immune activation; low mortality riskSupports discharge decisions
4.0 – 6.0Medium RiskSome disease activity / comorbidityMonitor and consider further evaluation
> 6.0High RiskHigh inflammation / immune activation; higher mortality riskAdmit and evaluate / treat

The suPARnostic® Quick Triage measures 1–15 ng/mL. Results outside this range appear as <1.0 ng/mL or >15 ng/mL. The reader automatically performs calibration to ensure accuracy.

ParameterSpecification
Measurement range1–15 ng/mL
Displayed if below range<1.0 ng/mL
Displayed if above range>15 ng/mL
CalibrationAutomatic via batch-specific QR/method barcode, loaded into the reader
Reader processOptical image capture + linear curve calibration based on 6 reference samples

Each cassette includes a control line (C-line) to verify proper test performance. The QT FLEX Reader also performs an internal self-check at startup and during every measurement cycle.

Errors may occur if samples are hemolyzed, frozen, expired, or incorrectly mixed. Incorrect cassette placement or barcode scanning can also lead to INVALID or BLANK results. The test should then be repeated.

The suPARnostic® brand consists of three products:

Quick Triage

A Point of Care Solution

Quick Triage

Turbi-Latex

For Automated Systems

TurbiLatex

ELISA Assay

Clinical and Research

ELISA

Read 1000+ published suPAR studies in leading medical journals

suPAR and inflammation in Nature Medicine medical and scientific Journal
suPAR and inflammation in The New England Journal of Medicine
suPAR and inflammation in Science AAAS Journal
suPAR and inflammation in JAMA medical and scientific journal
suPARnostic® by ViroGates